InvestorsHub Logo
Post# of 253534
Next 10
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

Re: None

Wednesday, 07/22/2015 1:48:25 PM

Wednesday, July 22, 2015 1:48:25 PM

Post# of 253534
CPRX: Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)
They are up big recently and 8% up today. They are about to release data on CP115 anyway now.
Anyone on this stock? I bought when AF wrote that none bearish article
I am interested in opinions on CP115 (CP119 data last june was good)
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.